medigraphic.com
Organo Oficial de la Sociedad Mexicana de Urología

2019, Number 5

<< Back Next >>

Rev Mex Urol 2019; 79 (5)

Epidemiologic profile of hospitalizations due to urolithiasisin the state of Yucatán, Mexico

Ortegón-Gallareta R, Aguilar-Moreno J, Pech-Cervantes PI, Álvarez-Baeza A, Méndez-Domínguez N

Language: Spanish
References: 35
Page: 1-11
PDF size: 260.96 Kb.


ABSTRACT

Objective: To describe the epidemiologic characteristics of patients hospitalized due to urolithiasis in the State of Yucatán, Mexico, compared with official state and national references.
Methodological design: A retrospective, descriptive, observational, cross-sectional study was conducted. It included the hospitalizations due to urolithiasis in the public health sector, within the time frame of 2014 to 2016 in Yucatán, comparing them with the official state and national references through hypothesis contrast tests for independent samples adjusted to population size.
Results: A total of 1078 hospitalizations due to urolithiasis in Yucatán were registered and 52.8% corresponded to male patients. The mean age at hospitalization was significantly lower in the female patients at both the state and national levels. The prevalence of obesity in the hospitalized patients was 33.33, which was not statistically different from that reported by the state. The number of hospitalizations of patients residing in the capital was significantly lower than expected (31.9 versus 52.9).
Limitations: The present study was restricted to public health sector hospitalization data, and therefore, private sector registers were excluded. Originality and value: The present analysis is the first epidemiologic study to compare and evaluate the epidemiologic factors of the registered cases of hospitalizations due to urolithiasis in the State of Yucatán.
Conclusions: There was a higher number of hospitalizations in the State of Yucatán than those registered nationally, resulting in the highest hospitalization rate in the country. Prevalence was slightly higher in men, whereas age was lower in women. The prevalence of obesity and the number of hospitalized patients of Mayan ancestry did not differ from the state registers. The number of hospitalized patients residing in the capital was lower than expected.


REFERENCES

  1. Medina-Escobedo M, Alcocer-Dzul R, López- López J, Villanueva-Jorge S. Obesidad como factor de riesgo para alteraciones metabólicas en adultos con litiasis urinaria. Rev Med Inst Mex Seguro Soc. 2015;53(6):692–7.

  2. Aragón-Tovar AR, Hernández-Farías M Análisis cristalográfico de 475 cálculos de vías urinarias en el Hospital San José, Tec Salud, en Monterrey, N.L. Rev Mex Urol. 2013 May 1;73(3):130–5.

  3. Fisang C, Anding R, Muller S, Latz S, Laube N. Urolithiasis an interdisciplinary diagnostic, therapeutic and secondary preventive challenge. Dtsch Arztebl Int. 2015;112(6):83–91. doi: 10.3238/arztebl.2015.0083

  4. Devarajan A. Cross-talk between renal lithogenesis and atherosclerosis: an unveiled link between kidney stone formation and cardiovascular diseases. Clin Sci. 2018;132(6):615–26. doi: 10.1042/CS20171574

  5. Jung H, Pless M, Osther P. Anatomic variations and stone formation. Curr Opin Urol. 2018;28(5):420–7. doi: 10.1097/ MOU.0000000000000519

  6. Evan AP, Worcester EM, Coe FL, Williams J, Lingeman JE. Mechanisms of human kidney stone formation. Urolithiasis. 2015;43(1):19– 32. doi: 10.1007/s00240-014-0701-0

  7. García-Perdomo HA, Solarte PB, España PP. Fisiopatología asociada a la formación de cálculos en la vía urinaria. Urología Colombiana. 2016;25(2):109–17. doi: 10.1016/j. uroco.2015.12.012

  8. Sánchez A, Sarano D, del Valle E. Nefrolitiasis. fisiopatología, evaluación metabólica y manejo terapéutico. Actual Ostel. 2011;7(3):195–234.

  9. Mejía LM, García-Perdomo HA, Contreras R. Manejo dietario para la prevención de urolitiasis. Urología Colombiana. 2014;23(3):214–8. doi: 10.1016/S0120-789X(14)50059-7

  10. Sofia NH, Manickavasakam K, Walter T. Prevalence and risk factors of kidney stone. Global Journal for Research Analysis. 2016;5(3):6.

  11. Krambeck Amy E., Lieske John C., Li Xujian, Bergstralh Eric J., Melton L. Joseph, Rule Andrew D. Effect of Age on the Clinical Presentation of Incident Symptomatic Urolithiasis in the General Population. J Urol. 2013;189(1):158–64. doi: 10.1016/j.juro.2012.09.023

  12. Medina-Escobedo M, Zaidi M, Real-de León E, Orozco-Rivadeneyra S. Prevalencia y factores de riesgo en Yucatán, México, para litiasis urinaria. Salud Pública Méx. 2002;44(6):541–5. doi: 10.1590/S0036-36342002000600006

  13. Sánchez-Martín F, Millán Rodríguez F, Esquena Fernández S, Segarra Tomás J, Rousaud Barón F, Martínez-Rodríguez R, et al. Incidencia y prevalencia de la urolitiasis en España: Revisión de los datos originales disponibles hasta la actualidad. Actas Urol Esp. 2007;31(5):511–20.

  14. Dardamanis M. Pathomechanisms of nephrolithiasis. Hippokratia. 2013;17(2):100–7.

  15. Scales CD, Lin L, Saigal CS, Bennett CJ, Ponce NA, Mangione CM, et al. Emergency Department Revisits for Patients with Kidney Stones in California. Acad Emerg Med. 2015;22(4):468–74. doi: 10.1111/acem.12632

  16. Morgan MSC, Pearle MS. Medical management of renal stones. BMJ. 2016; 352:i52. doi: 10.1136/bmj.i52

  17. INEGI IN de E y G. Instituto Nacional de Estadística y Geografía. INEGI. [accessed 4 Nov 2019] Available from: https://www.inegi.org. mx/

  18. Mendez N, Barrera-Pérez TLM, Palma-Solis M, Zavala-Castro J, Dickinson F, Azcorra H, et al. Ethnicity and income impact on BMI and stature of school children living in urban southern Mexico. J Biosoc Sci. 2016;48(2):143–57. doi: 10.1017/S0021932015000127

  19. Consejo Nacional de Población | Gobierno | gob.mx. [accessed 4 Nov 2019] Available from: https://www.gob.mx/conapo

  20. Encuesta Nacional de Salud y Nutrición. ENSANUT. [accessed 4 Nov 2019] Available from: https://ensanut.insp.mx/encuestas/ ensanut2016/index.php

  21. Johnson R, Bhattacharyya G. Statistics: Principles and Methods, 8th ed. Willey; 2019. 630 p.

  22. Masterson JH, Woo JR, Chang DC, Chi T, L’Esperance JO, Stoller ML, et al. Dyslipidemia is associated with an increased risk of nephrolithiasis. Urolithiasis. 2015;43(1):49–53. doi: 10.1007/s00240-014-0719-3

  23. Khan SR, Pearle MS, Robertson WG, Gambaro G, Canales BK, Doizi S, et al. Kidney stones. Nat Rev Dis Primers. 2016;2(1):1–23. doi: 10.1038/ nrdp.2016.8

  24. Elmendorf ML. Conclusion: Reflections on Rights, Resources, and Responsibilities. In: Participatory Research Rights, Resources, Culture, and Conservation in the Land of the Maya. 1st ed. United States of America: Praeger; 2004. p. 295.

  25. Leatherman T, Goodman A, Stillman T. Changes in stature, weight, and nutritional status with tourism-based economic development in the Yucatan. Economics and human biology. 2010; 8:153–8. doi: 10.1016/j.ehb.2010.05.008

  26. Mendez N, Barrera-Perez M, Palma-Solís MA, Burguete MTC, Prelip M. Policies and Programs to Improve Physical Activity, Eating Practices, and Water Consumption in Merida, Yucatan (Mexico) Public Schools. Health Behavior and Policy Review. 2015;2(6):450–60. doi: 10.14485/HBPR.2.6.5

  27. Azcorra H, Wilson H, Bogin B, Varela-Silva MI, Vázquez-Vázquez A, Dickinson F. Dietetic characteristics of a sample of Mayan dual burden households in Merida, Yucatan, Mexico. Archivos Latinoamericanos de Nutrición. 2014;63(3):209–17.

  28. Villanueva Villanueva NB, Güémez Pineda MA. Lineamientos generales para el diseño de un modelo intercultural de atención a la salud de inmigrantes mayas yucatecos en San Francisco, California. Península. 2016;11(2):49–74.

  29. Saldana T, Basso O, Darden R, Sandler D. Carbonated Beverages and Chronic Kidney Disease. Epidemiology. 2007;18(4):501–6. doi: 10.1097/EDE.0b013e3180646338

  30. Ferraro PM, Taylor EN, Gambaro G, Curhan GC. Soda and Other Beverages and the Risk of Kidney Stones. Clin J Am Soc Nephrol. 2013;8(8):1389–95. doi: 10.2215/ CJN.11661112

  31. Berry NS. Who’s Judging the Quality of Care? Indigenous Maya and the Problem of “Not Being Attended”. Medical Anthropology. 2008;27(2):164–89. doi: 10.1080/01459740802017413

  32. Loyola-Sanchez A, Richardson J, Wilkins S, Lavis JN, Wilson MG, Alvarez-Nemegyei J, et al. Barriers to accessing the culturally sensitive healthcare that could decrease the disabling effects of arthritis in a rural Mayan community: a qualitative inquiry. Clin Rheumatol. 2016;35(5):1287–98. doi: 10.1007/ s10067-015-3061-4

  33. Medina VG. Youth, Poverty and Exclusion: Health problems of young Mayans in Yucatan. Social Medicine. 2010;5(2):100–5.

  34. Fletcher RH, Fletcher SW, Fletcher GS. Clinical Epidemiology: The Essentials. 5th ed. China: Lippincott Williams & Wilkins; 2014. 275 p.

  35. Peerapen P, Thongboonkerd V. Caffeine in Kidney Stone Disease: Risk or Benefit? Adv Nutr. 2018;9(4):419–24. doi: 10.1093/advances/ nmy016




2020     |     www.medigraphic.com